Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment.
about
Pre-exposure prophylaxis for sexually-acquired HIV risk management: a reviewOral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challengesAntiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxisImpact of an adherence intervention on the effectiveness of tenofovir gel in the CAPRISA 004 trial.Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence.Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection.HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative studyAn interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal ringsClinical Treatment Options Infectious Diseases: Update on PrEP Implementation, Adherence, and Advances in DeliveryPerceptions and Experiences with the VOICE Adherence Strengthening Program (VASP) in the MTN-003 Trial.Development and pilot testing of an intervention to promote care engagement and adherence among HIV-positive Kenyan MSM.Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana.Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City.Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials.Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study.Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations.Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco.How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention.From trials to the public health: pre-exposure prophylaxis for HIV prevention.Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.Assessing the cost effectiveness of pre-exposure prophylaxis for HIV prevention in the US.Acceptability of drug detection monitoring among participants in an open-label pre-exposure prophylaxis study.Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men.Diminishing Perceived Threat of AIDS and Increasing Sexual Risks of HIV Among Men Who Have Sex with Men, 1997-2015.An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM.Community Federally Qualified Health Centers as Homes for HIV Preexposure Prophylaxis: Perspectives from South Florida.Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study.Brief Participant-Centered Convergence Interviews Integrate Self-Reports, Product Returns, and Pharmacokinetic Results to Improve Adherence Measurement in MTN-017.Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.Women and ARV-based prevention: opportunities and challenges.Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study.A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis.Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection.Pre-exposure Prophylaxis as HIV Prevention in High Risk AdolescentsEfficacy and Safety of Oral TDF-Based Pre-exposure Prophylaxis for Men Who Have Sex With Men: A Systematic Review and Meta-AnalysisUniversity of North Carolina/Emory Center for Innovative Technology (iTech) for Addressing the HIV Epidemic Among Adolescents and Young Adults in the United States: Protocol and Rationale for Center Development
P2860
Q26849762-E6847C76-74F3-4018-BF36-D5DFC6BB119DQ27023352-47152A57-C65C-4F29-8314-D5ED40D99E13Q28085433-EB137C7B-227A-4052-83D7-FB52E562D8D3Q33570985-2F4E92ED-7323-4DD9-9C4D-C8FF7DF5D0E0Q33765789-E5A1BEE9-48B9-429E-816D-FB61C8429143Q33948938-8C9A6082-B24A-4996-B9CE-52A8F78F2904Q34022199-615709C0-5CDB-4AC8-9637-CC3419266596Q34180658-FFDB4F8A-B71B-48C6-8AB2-50494220A753Q35541521-BDEEDE7A-91E2-4DB0-B1BE-3FE69AA2E298Q35561492-87A1AE76-BC85-4F7E-9B36-5F824FB532A7Q36445324-A21B010F-B294-40E9-B399-9A9B5506C210Q36451510-D86AC80B-5A2C-4FFF-BA25-C11CB843D31FQ36710299-DC50A777-CDA0-4ACD-B507-D4CABF330A4AQ36760768-E101ADD7-A15B-4E7A-ABFD-7559F6556960Q36902453-7FFF2200-6BF8-47BA-B46C-0CF83F8E821BQ36994992-BE94709F-C2C8-4085-9A67-FFAEDD95FE77Q37003069-36A4A2AD-B375-4289-8E9F-A17849639FD8Q37216377-BFAC6119-727F-4680-9703-6A1C65D0059AQ37526187-BC6A12D8-785D-4863-B642-6C7CD9D97668Q37727482-5DA9C531-41E7-46C5-8BF6-66D451BC121FQ37736062-62365A9D-6CA9-4405-A469-D44EE0865B90Q38165803-87333261-3D9C-4538-BBB5-3E3A6EA68574Q39003651-29F5B28E-BE13-4126-94FD-83EB23007550Q39259966-408E5E1F-EE6C-4BF5-AC0E-4C04151649A5Q40342242-FF629887-68C2-4728-BD2E-C5B07863B2A2Q40538934-C177A71B-E53D-4EA0-B68B-DA92855485A8Q40583679-3B30867D-B108-451C-B2BF-FBC0FA9829D3Q46103694-60A0B8F7-AB6F-4180-9D73-875D3E3032C0Q46200255-40D7CCA6-EC9A-4A47-BC22-151584541814Q46333832-E11CB878-AE22-4913-AAA4-4CFA23A7F2E5Q46553256-2074A596-B313-43AD-BD56-42B7B6736C9BQ50053529-136395C9-465E-4D10-96A1-F0FEF21CEE66Q51736694-1389D80D-CF6C-40BB-95B1-8319E5FC15CAQ53769213-18A559A9-F931-4474-84D2-015628AFC281Q56394565-85332F49-ACF8-4F8B-841F-F94036DC62E5Q58764729-F3EFC9FF-6435-4A8E-BCA2-9F71835959FBQ58801172-2D1F261F-6CB0-45E9-BAA3-96D13C5C6CF1
P2860
Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Supporting study product use a ...... seling and neutral assessment.
@en
Supporting study product use a ...... seling and neutral assessment.
@nl
type
label
Supporting study product use a ...... seling and neutral assessment.
@en
Supporting study product use a ...... seling and neutral assessment.
@nl
prefLabel
Supporting study product use a ...... seling and neutral assessment.
@en
Supporting study product use a ...... seling and neutral assessment.
@nl
P2093
P2860
P1433
P1476
Supporting study product use a ...... seling and neutral assessment.
@en
P2093
Albert Liu
Julia L Marcus
Lorena Vargas
Pedro Goicochea
Vanessa McMahan
P2860
P2888
P304
P356
10.1007/S10461-012-0182-5
P577
2012-07-01T00:00:00Z